| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T52 |
0-5 |
Sentence |
denotes |
S.No. |
| T53 |
6-171 |
Sentence |
denotes |
Clinical trial number Study Title Phase Status Sample Size(n) CellularInterventions Date of Start (DOS)Date of Completion (DOC) Gender(Male/Female/ Both) Age Country |
| T54 |
172-304 |
Sentence |
denotes |
1- NCT04315987 Nest Cell ®Mesenchymal Stem Cell to Treat Patients with Severe COVID19 Pneumonia I Not Recruiting 66 Nest Cell ® DOS: |
| T55 |
305-315 |
Sentence |
denotes |
April 2020 |
| T56 |
316-320 |
Sentence |
denotes |
DOC: |
| T57 |
321-360 |
Sentence |
denotes |
June 2020 Both 18 Yrs. and older Brazil |
| T58 |
361-479 |
Sentence |
denotes |
2- NCT04313322 Treatment of COVID19 Patients Using Wharton’s Jelly- Mesenchymal Stem Cells I Recruiting 5 WJ-MSCs DOS: |
| T59 |
480-490 |
Sentence |
denotes |
March 2020 |
| T60 |
491-539 |
Sentence |
denotes |
DOC:September 2020 Both 18 Yrs. and older Jordan |
| T61 |
540-667 |
Sentence |
denotes |
3- NCT04288102 Treatment With Mesenchymal Stem Cells for Severe Corona Virus Diseases 2019 (COVID19) II Recruiting 90 MSCs DOS: |
| T62 |
668-678 |
Sentence |
denotes |
March 2020 |
| T63 |
679-683 |
Sentence |
denotes |
DOC: |
| T64 |
684-711 |
Sentence |
denotes |
July 2020 Both 18 to75 Yrs. |
| T65 |
712-717 |
Sentence |
denotes |
China |
| T66 |
718-863 |
Sentence |
denotes |
4- NCT04302519 Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells Early phaseI Not Recruiting 24 DPSCs DOS: |
| T67 |
864-874 |
Sentence |
denotes |
March 2020 |
| T68 |
875-879 |
Sentence |
denotes |
DOC: |
| T69 |
880-909 |
Sentence |
denotes |
July 2021 Both 18 to75 Yrs. – |
| T70 |
910-1042 |
Sentence |
denotes |
5- NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus I Recruiting 20 MSCs DOS: |
| T71 |
1043-1055 |
Sentence |
denotes |
January 2020 |
| T72 |
1056-1060 |
Sentence |
denotes |
DOC: |
| T73 |
1061-1092 |
Sentence |
denotes |
December 2021 Both 18 to70 Yrs. |
| T74 |
1093-1098 |
Sentence |
denotes |
China |
| T75 |
1099-1254 |
Sentence |
denotes |
6- NCT04273646 Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Novel Coronavirus Severe Pneumonia – Not Recruiting 48 UC-MSCs DOS: |
| T76 |
1255-1265 |
Sentence |
denotes |
April 2020 |
| T77 |
1266-1270 |
Sentence |
denotes |
DOC: |
| T78 |
1271-1303 |
Sentence |
denotes |
February 2022 Both 18 to 65 Yrs. |
| T79 |
1304-1309 |
Sentence |
denotes |
China |
| T80 |
1310-1490 |
Sentence |
denotes |
7- NCT04276987 A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia I Not Recruiting 30 Exosomes derived from AD-MSCs |
| T81 |
1491-1506 |
Sentence |
denotes |
(MSCs-Exo) DOS: |
| T82 |
1507-1520 |
Sentence |
denotes |
February 2020 |
| T83 |
1521-1525 |
Sentence |
denotes |
DOC: |
| T84 |
1526-1555 |
Sentence |
denotes |
July 2020 Both 18 to75 Yrs. – |
| T85 |
1556-1565 |
Sentence |
denotes |
8- NCT043 |
| T86 |
1566-1592 |
Sentence |
denotes |
36,254 Safety and Efficacy |
| T87 |
1593-1612 |
Sentence |
denotes |
Study of Allogeneic |
| T88 |
1613-1630 |
Sentence |
denotes |
Human Dental Pulp |
| T89 |
1631-1647 |
Sentence |
denotes |
Mesenchymal Stem |
| T90 |
1648-1669 |
Sentence |
denotes |
Cells to Treat Severe |
| T91 |
1670-1720 |
Sentence |
denotes |
COVID19 Patients I and II Recruiting 20 DPSCs DOS: |
| T92 |
1721-1731 |
Sentence |
denotes |
April 2020 |
| T93 |
1732-1736 |
Sentence |
denotes |
DOC: |
| T94 |
1737-1742 |
Sentence |
denotes |
March |
| T95 |
1743-1766 |
Sentence |
denotes |
2021 Both 18 to 65 Yrs. |
| T96 |
1767-1772 |
Sentence |
denotes |
China |
| T97 |
1773-1782 |
Sentence |
denotes |
9- NCT043 |
| T98 |
1783-1828 |
Sentence |
denotes |
39,660 Clinical Research of Human Mesenchymal |
| T99 |
1829-1913 |
Sentence |
denotes |
Stem Cells in the Treatment of COVID19 Pneumonia I and II Recruiting 30 UC-MSCs DOS: |
| T100 |
1914-1927 |
Sentence |
denotes |
February 2020 |
| T101 |
1928-1932 |
Sentence |
denotes |
DOC: |
| T102 |
1933-1961 |
Sentence |
denotes |
June 2020 Both 18 to 75 Yrs. |
| T103 |
1962-1967 |
Sentence |
denotes |
China |
| T104 |
1968-1978 |
Sentence |
denotes |
10- NCT043 |
| T105 |
1979-2005 |
Sentence |
denotes |
46,368 Bone Marrow-Derived |
| T106 |
2006-2022 |
Sentence |
denotes |
Mesenchymal Stem |
| T107 |
2023-2041 |
Sentence |
denotes |
Cell Treatment for |
| T108 |
2042-2062 |
Sentence |
denotes |
Severe Patients With |
| T109 |
2063-2082 |
Sentence |
denotes |
Coronavirus Disease |
| T110 |
2083-2110 |
Sentence |
denotes |
2019 (COVID19) I and II Not |
| T111 |
2111-2137 |
Sentence |
denotes |
Recruiting 20 BM-MSCs DOS: |
| T112 |
2138-2148 |
Sentence |
denotes |
April 2020 |
| T113 |
2149-2153 |
Sentence |
denotes |
DOC: |
| T114 |
2154-2162 |
Sentence |
denotes |
December |
| T115 |
2163-2186 |
Sentence |
denotes |
2020 Both 18 to 75 Yrs. |
| T116 |
2187-2192 |
Sentence |
denotes |
China |
| T117 |
2193-2203 |
Sentence |
denotes |
11- NCT043 |
| T118 |
2204-2230 |
Sentence |
denotes |
52,803 Adipose Mesenchymal |
| T119 |
2231-2253 |
Sentence |
denotes |
Cells for Abatement of |
| T120 |
2254-2264 |
Sentence |
denotes |
SARS CoV-2 |
| T121 |
2265-2276 |
Sentence |
denotes |
Respiratory |
| T122 |
2277-2290 |
Sentence |
denotes |
Compromise in |
| T123 |
2291-2340 |
Sentence |
denotes |
COVID-19 Disease I Not Recruiting 20 AD-MSCs DOS: |
| T124 |
2341-2351 |
Sentence |
denotes |
April 2020 |
| T125 |
2352-2356 |
Sentence |
denotes |
DOC: |
| T126 |
2357-2388 |
Sentence |
denotes |
April 2026 Both 18 to 90 Yrs. – |
| T127 |
2389-2399 |
Sentence |
denotes |
12- NCT043 |
| T128 |
2400-2426 |
Sentence |
denotes |
49,631 A Clinical Trial to |
| T129 |
2427-2447 |
Sentence |
denotes |
Determine the Safety |
| T130 |
2448-2468 |
Sentence |
denotes |
and Efficacy of Hope |
| T131 |
2469-2480 |
Sentence |
denotes |
Biosciences |
| T132 |
2481-2491 |
Sentence |
denotes |
Autologous |
| T133 |
2492-2508 |
Sentence |
denotes |
Mesenchymal Stem |
| T134 |
2509-2532 |
Sentence |
denotes |
Cell Therapy (HBadMSCs) |
| T135 |
2533-2543 |
Sentence |
denotes |
to Provide |
| T136 |
2544-2562 |
Sentence |
denotes |
Protection Against |
| T137 |
2563-2586 |
Sentence |
denotes |
COVID19 II Enrolling by |
| T138 |
2587-2613 |
Sentence |
denotes |
invitation 56 AD-MSCs DOS: |
| T139 |
2614-2622 |
Sentence |
denotes |
May 2020 |
| T140 |
2623-2627 |
Sentence |
denotes |
DOC: |
| T141 |
2628-2660 |
Sentence |
denotes |
December 2020 Both Child, Adult, |
| T142 |
2661-2666 |
Sentence |
denotes |
Older |
| T143 |
2667-2686 |
Sentence |
denotes |
Adult United States |
| T144 |
2687-2697 |
Sentence |
denotes |
13- NCT030 |
| T145 |
2698-2720 |
Sentence |
denotes |
42,143 Repair of Acute |
| T146 |
2721-2741 |
Sentence |
denotes |
Respiratory Distress |
| T147 |
2742-2761 |
Sentence |
denotes |
Syndrome by Stromal |
| T148 |
2762-2781 |
Sentence |
denotes |
Cell Administration |
| T149 |
2782-2801 |
Sentence |
denotes |
(REALIST) (COVID19) |
| T150 |
2802-2870 |
Sentence |
denotes |
(REALIST) I and II Recruiting 75 UC derived CD362 enriched MSCs DOS: |
| T151 |
2871-2883 |
Sentence |
denotes |
January 2019 |
| T152 |
2884-2888 |
Sentence |
denotes |
DOC: |
| T153 |
2889-2939 |
Sentence |
denotes |
October 2022 Both 16 Yrs. and older United Kingdom |
| T154 |
2940-2950 |
Sentence |
denotes |
14- NCT043 |
| T155 |
2951-3002 |
Sentence |
denotes |
90,152 Safety and Efficacy of Intravenous Wharton’s |
| T156 |
3003-3016 |
Sentence |
denotes |
Jelly Derived |
| T157 |
3017-3033 |
Sentence |
denotes |
Mesenchymal Stem |
| T158 |
3034-3048 |
Sentence |
denotes |
Cells in Acute |
| T159 |
3049-3069 |
Sentence |
denotes |
Respiratory Distress |
| T160 |
3070-3133 |
Sentence |
denotes |
Syndrome due to COVID19 I and II Not Recruiting 40 WJ-MSCs DOS: |
| T161 |
3134-3143 |
Sentence |
denotes |
June 2020 |
| T162 |
3144-3148 |
Sentence |
denotes |
DOC: |
| T163 |
3149-3176 |
Sentence |
denotes |
May 2021 Both 18 to 80 Yrs. |
| T164 |
3177-3185 |
Sentence |
denotes |
Colombia |
| T165 |
3186-3196 |
Sentence |
denotes |
15- NCT043 |
| T166 |
3197-3216 |
Sentence |
denotes |
82,547 Treatment of |
| T167 |
3217-3235 |
Sentence |
denotes |
COVID19 Associated |
| T168 |
3236-3250 |
Sentence |
denotes |
Pneumonia with |
| T169 |
3251-3267 |
Sentence |
denotes |
Allogenic Pooled |
| T170 |
3268-3291 |
Sentence |
denotes |
Olfactory Mucosaderived |
| T171 |
3292-3303 |
Sentence |
denotes |
Mesenchymal |
| T172 |
3304-3354 |
Sentence |
denotes |
Stem Cells I and II Not Recruiting 40 OM-MSCs DOS: |
| T173 |
3355-3363 |
Sentence |
denotes |
May 2020 |
| T174 |
3364-3368 |
Sentence |
denotes |
DOC: |
| T175 |
3369-3396 |
Sentence |
denotes |
June 2021 Both 18 to70 Yrs. |
| T176 |
3397-3404 |
Sentence |
denotes |
Belarus |
| T177 |
3405-3415 |
Sentence |
denotes |
16- NCT043 |
| T178 |
3416-3447 |
Sentence |
denotes |
66,323 Clinical Trial to Assess |
| T179 |
3448-3462 |
Sentence |
denotes |
the Safety and |
| T180 |
3463-3486 |
Sentence |
denotes |
Efficacy of Intravenous |
| T181 |
3487-3521 |
Sentence |
denotes |
Administration of Allogeneic Adult |
| T182 |
3522-3538 |
Sentence |
denotes |
Mesenchymal Stem |
| T183 |
3539-3556 |
Sentence |
denotes |
Cells of Expanded |
| T184 |
3557-3660 |
Sentence |
denotes |
Adipose Tissue in Patients with Severe Pneumonia due to COVID19 I and II Not Recruiting 26 AD-MSCs DOS: |
| T185 |
3661-3671 |
Sentence |
denotes |
April 2020 |
| T186 |
3672-3676 |
Sentence |
denotes |
DOC: |
| T187 |
3677-3710 |
Sentence |
denotes |
October 2021 Both 18 to 80 Yrs. – |
| T188 |
3711-3721 |
Sentence |
denotes |
17- NCT043 |
| T189 |
3722-3745 |
Sentence |
denotes |
66,063 Mesenchymal Stem |
| T190 |
3746-3781 |
Sentence |
denotes |
Cell Therapy for SARS-CoV-2-related |
| T191 |
3782-3799 |
Sentence |
denotes |
Acute Respiratory |
| T192 |
3800-3895 |
Sentence |
denotes |
Distress Syndrome II and III Recruiting 60 MSCs, and Exosomes derived from MSCs (MSCs-Exo) DOS: |
| T193 |
3896-3906 |
Sentence |
denotes |
April 2020 |
| T194 |
3907-3911 |
Sentence |
denotes |
DOC: |
| T195 |
3912-3944 |
Sentence |
denotes |
December 2020 Both 18 to 65 Yrs. |
| T196 |
3945-3949 |
Sentence |
denotes |
Iran |
| T197 |
3950-3960 |
Sentence |
denotes |
18- NCT043 |
| T198 |
3961-3984 |
Sentence |
denotes |
77,334 Mesenchymal Stem |
| T199 |
3985-4014 |
Sentence |
denotes |
Cells (MSCs) in Inflammation- |
| T200 |
4015-4034 |
Sentence |
denotes |
Resolution Programs |
| T201 |
4035-4049 |
Sentence |
denotes |
of Coronavirus |
| T202 |
4050-4062 |
Sentence |
denotes |
Disease 2019 |
| T203 |
4063-4080 |
Sentence |
denotes |
(COVID19) Induced |
| T204 |
4081-4098 |
Sentence |
denotes |
Acute Respiratory |
| T205 |
4099-4116 |
Sentence |
denotes |
Distress Syndrome |
| T206 |
4117-4157 |
Sentence |
denotes |
(ARDS) II Not Recruiting 40 BM-MSCs DOS: |
| T207 |
4158-4166 |
Sentence |
denotes |
May 2020 |
| T208 |
4167-4171 |
Sentence |
denotes |
DOC: |
| T209 |
4172-4216 |
Sentence |
denotes |
February 2021 Both 18 Yrs. and older Germany |
| T210 |
4217-4227 |
Sentence |
denotes |
19- NCT043 |
| T211 |
4228-4250 |
Sentence |
denotes |
71,393 MSCs in COVID19 |
| T212 |
4251-4279 |
Sentence |
denotes |
ARDS III Recruiting 300 MSCs |
| T213 |
4280-4298 |
Sentence |
denotes |
Remestemcel-L DOS: |
| T214 |
4299-4313 |
Sentence |
denotes |
April 30, 2020 |
| T215 |
4314-4318 |
Sentence |
denotes |
DOC: |
| T216 |
4319-4366 |
Sentence |
denotes |
April 2022 Both 18 Yrs. and older United States |
| T217 |
4367-4377 |
Sentence |
denotes |
20- NCT043 |
| T218 |
4378-4404 |
Sentence |
denotes |
62,189 Efficacy and Safety |
| T219 |
4405-4424 |
Sentence |
denotes |
Study of Allogeneic |
| T220 |
4425-4498 |
Sentence |
denotes |
HB-adMSCs for the Treatment of COVID19 II Not Recruiting 110 AD-MSCs DOS: |
| T221 |
4499-4507 |
Sentence |
denotes |
May 2020 |
| T222 |
4508-4512 |
Sentence |
denotes |
DOC: |
| T223 |
4513-4537 |
Sentence |
denotes |
October 2020 Both Child, |
| T224 |
4538-4544 |
Sentence |
denotes |
Adult, |
| T225 |
4545-4550 |
Sentence |
denotes |
Older |
| T226 |
4551-4570 |
Sentence |
denotes |
Adult United States |
| T227 |
4571-4581 |
Sentence |
denotes |
21- NCT043 |
| T228 |
4582-4606 |
Sentence |
denotes |
66,271 Clinical Trial of |
| T229 |
4607-4617 |
Sentence |
denotes |
Allogeneic |
| T230 |
4618-4635 |
Sentence |
denotes |
Mesenchymal Cells |
| T231 |
4636-4655 |
Sentence |
denotes |
from Umbilical Cord |
| T232 |
4656-4679 |
Sentence |
denotes |
Tissue in Patients with |
| T233 |
4680-4718 |
Sentence |
denotes |
COVID19 II Recruiting 106 UC-MSCs DOS: |
| T234 |
4719-4727 |
Sentence |
denotes |
May 2020 |
| T235 |
4728-4732 |
Sentence |
denotes |
DOC: |
| T236 |
4733-4760 |
Sentence |
denotes |
May 2021 Both 40 to 80 Yrs. |
| T237 |
4761-4766 |
Sentence |
denotes |
Spain |
| T238 |
4767-4777 |
Sentence |
denotes |
22- NCT043 |
| T239 |
4778-4798 |
Sentence |
denotes |
48,435 A Randomized, |
| T240 |
4799-4812 |
Sentence |
denotes |
Double-Blind, |
| T241 |
4813-4831 |
Sentence |
denotes |
Placebo-Controlled |
| T242 |
4832-4891 |
Sentence |
denotes |
Clinical Trial to Determine the Safety and Efficacy of Hope |
| T243 |
4892-4903 |
Sentence |
denotes |
Biosciences |
| T244 |
4904-4914 |
Sentence |
denotes |
Allogeneic |
| T245 |
4915-4931 |
Sentence |
denotes |
Mesenchymal Stem |
| T246 |
4932-5037 |
Sentence |
denotes |
Cell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: |
| T247 |
5038-5048 |
Sentence |
denotes |
April 2020 |
| T248 |
5049-5053 |
Sentence |
denotes |
DOC: |
| T249 |
5054-5076 |
Sentence |
denotes |
April 2021 Both Child, |
| T250 |
5077-5089 |
Sentence |
denotes |
Adult, Older |
| T251 |
5090-5109 |
Sentence |
denotes |
Adult United States |
| T252 |
5110-5120 |
Sentence |
denotes |
23- NCT043 |
| T253 |
5121-5172 |
Sentence |
denotes |
71,601 Safety and Effectiveness of Mesenchymal Stem |
| T254 |
5173-5288 |
Sentence |
denotes |
Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 Early Phase I Active not Recruiting 60 UC-MSCs DOS: |
| T255 |
5289-5299 |
Sentence |
denotes |
March 2020 |
| T256 |
5300-5304 |
Sentence |
denotes |
DOC: |
| T257 |
5305-5337 |
Sentence |
denotes |
December 2022 Both 18 to 70 Yrs. |
| T258 |
5338-5343 |
Sentence |
denotes |
China |
| T259 |
5344-5354 |
Sentence |
denotes |
24- NCT043 |
| T260 |
5355-5433 |
Sentence |
denotes |
55,728 Use of UC-MSCs for COVID19 Patients I and II Recruiting 24 UC-MSCs DOS: |
| T261 |
5434-5444 |
Sentence |
denotes |
April 2020 |
| T262 |
5445-5449 |
Sentence |
denotes |
DOC: |
| T263 |
5450-5495 |
Sentence |
denotes |
May 2021 Both 18 Yrs. and older United States |
| T264 |
5496-5506 |
Sentence |
denotes |
25- NCT043 |
| T265 |
5507-5534 |
Sentence |
denotes |
92,778 Clinical Use of Stem |
| T266 |
5535-5605 |
Sentence |
denotes |
Cells for the Treatment of COVID19 I and II Recruiting 30 UC-MSCs DOS: |
| T267 |
5606-5616 |
Sentence |
denotes |
April 2020 |
| T268 |
5617-5621 |
Sentence |
denotes |
DOC: |
| T269 |
5622-5655 |
Sentence |
denotes |
September 2020 Both 40 to 60 Yrs. |
| T270 |
5656-5662 |
Sentence |
denotes |
Turkey |
| T271 |
5663-5673 |
Sentence |
denotes |
26- NCT043 |
| T272 |
5674-5843 |
Sentence |
denotes |
97,796 Study of the Safety of Therapeutic Tx with Immunomodulatory MSC in Adults with COVID19 Infection Requiring Mechanical Ventilation I Not Recruiting 45 BM-MSCs DOS: |
| T273 |
5844-5853 |
Sentence |
denotes |
June 2020 |
| T274 |
5854-5858 |
Sentence |
denotes |
DOC: |
| T275 |
5859-5889 |
Sentence |
denotes |
June 2021 Both 18 to 80 Yrs. – |
| T276 |
5890-5900 |
Sentence |
denotes |
27- NCT043 |
| T277 |
5901-5927 |
Sentence |
denotes |
90,139 Efficacy and Safety |
| T278 |
5928-5958 |
Sentence |
denotes |
Evaluation of Mesenchymal Stem |
| T279 |
5959-5994 |
Sentence |
denotes |
Cells for the Treatment of Patients |
| T280 |
5995-6011 |
Sentence |
denotes |
with Respiratory |
| T281 |
6012-6067 |
Sentence |
denotes |
Distress to COVID19 I and II Recruiting 30 WJ-MSCs DOS: |
| T282 |
6068-6076 |
Sentence |
denotes |
May 2020 |
| T283 |
6077-6081 |
Sentence |
denotes |
DOC: |
| T284 |
6082-6114 |
Sentence |
denotes |
December 2020 Both 18 to 75 Yrs. |
| T285 |
6115-6120 |
Sentence |
denotes |
Spain |
| T286 |
6121-6131 |
Sentence |
denotes |
28- NCT042 |
| T287 |
6132-6179 |
Sentence |
denotes |
69,525 Umbilical Cord (UC)- Derived Mesenchymal |
| T288 |
6180-6197 |
Sentence |
denotes |
Stem Cells (MSCs) |
| T289 |
6198-6285 |
Sentence |
denotes |
Treatment for the 2019-novel Coronavirus (nCOV) Pneumonia II Recruiting 10 UC-MSCs DOS: |
| T290 |
6286-6299 |
Sentence |
denotes |
February 2020 |
| T291 |
6300-6304 |
Sentence |
denotes |
DOC: |
| T292 |
6305-6338 |
Sentence |
denotes |
September 2020 Both 18 to 75 Yrs. |
| T293 |
6339-6344 |
Sentence |
denotes |
China |
